About HBOT of Arizona

conditions treatable with oxygen therapy

sign our guestbook

home to oxygen therapy

subscribe to our free newsletter

q & a hyperbaric oxygen therapy

Resources, links, research on HBOT

testimonials about hyperbaric oxygen therapy of az

Hyperbaric oxygen therapy clinic in Arizona

Hyperbaric Oxygen Therapy

by Grim, Pamela S.; Gottlieb, Lawrence J.; Boddie, Allyn; Batson, Er

 
Abstract
 
     Hyperbaric oxygen (HBO) therapy involves intermittent  inhalation
     of pure oxygen under a pressure greater than one atmosphere.
 
     During  the  1960s,  HBO  was proposed as a treatment for cancer,
     heart  attack,  senility,  and  other  conditions,  but  research
     studies  did  not  obtain  reproducible  results.  The skepticism
     engendered among medical personnel by these failures extended  to
     HBO's use for treating clinical conditions that it had been shown
     to  help. A review of these conditions is provided. HBO acts both
     mechanically, due to its pressure component, and physiologically,
     due to its oxygen component.
 
     HBO therapy has been effective in treating decompression sickness
     (the illness  resulting  from  too-rapid  changes  in pressure by
     divers or aviators), and air embolism (introduction of  air  into
     the   circulatory   system,   often  unintentionally  by  medical
     personnel) by mechanically reducing the  size of gas bubbles, and
     increasing oxygen levels in the blood.
 
     Oxygen is essential for proper function of certain cells  of  the
     immune  system  and, in certain injuries, such as burns and crush
     injuries, HBO treatment  can  increase  the  supply  of oxygen to
     tissues otherwise deprived of it. Complications of HBO  treatment
     include trauma to or rupture of cavities, neurotoxicity resulting
     from  exposure  to 100 percent oxygen for long periods, and other
     sequelae.
 
     HBO  therapy  is   indicated   for  decompression  sickness,  air
     embolism, carbon monoxide  poisoning,  acute  traumatic  ischemia
     (crush  injuries  that  deprive tissues of oxygen), and bacterial
     invasion of a necrotic wound (in  which tissue has died). HBO may
     also stimulate  regrowth  of  blood  vessels  in  damaged  tissue
     adjacent  to  areas  treated by radiation therapy and may promote
     bone formation in  cases  of  osteomyelitis (bone infection) that
     have not responded to other treatments. This therapy  also  shows
     promise   for   treating  a  variety  of  'problem  wounds',  but
     randomized, prospective studies are lacking.
 
     Overall,  HBO  therapy   is   safe   and  effective  for  certain
     conditions, and  well-formulated  clinica  l  trials  could  help
     extend  its use to others. (Consumer Summary produced by Reliance
     Medical Information, Inc.)
 
     hyperbaric oxygen and briefly evaluates animal and clinical  data
     substantiating these indications. Areas in which the mechanism of
     action of hyperbaric oxygen is still not well understood, as well
     as possible new areas of applications, are discussed.
 
     HYPERBARIC  oxygen (HBO) therapy involves intermittent inhalation
     of 100% oxygen under a pressure greater than 1 atm. [1]
 
     Both therapeutic and toxic  effects  result  from two features of
     treatment: mechanical effects of  increased  pressure  and
      physiologic effects of hyperoxia.
 
     Hyperbaric  oxygen  therapy  has  long been accepted as a primary
     treatment for decompression sickness [2]; however, other proposed
     indications have been controversial.  During  the 1960s there was
     widespread enthusiasm  for  hyperbaric  treatment  of  myocardial
     infarction,  stroke, senility, and cancer. Enthusiasm waned after
     results of clinical trials  (and direct experience) showed little
     benefit for these diseases.  The  overzealous  claims  about  the
     effectiveness  of  HBO  therapy  have left a legacy of skepticism
     among physicians. [3]  However,  animal studies, clinical trials,
     and greater clinical experience over the last  two  decades  have
     produced  a  set  of  indications  for  which HBO therapy appears
     beneficial. These clinical conditions are substantially different
     from those  in  the  1960s.  However,  there  has  been no recent
     interdisciplinary review of HBO therapy delineating these current
     indications, despite their broad applications.
 
     Thus, while substantial evidence supports use of HBO  therapy  in
     certain  carefully  de  fined  settings,  many patients who might
     benefit go untreated  because  of  their physician's unfamilarity
     with recent research and overall uncertainty about the legitimacy
     of HBO as therapy. We discuss the  mechanism  of  action  of  HBO
     therapy  and the commonly accepted clinical indications (Table 1)
     as delineated by the Undersea and Hyperbaric Medical Society, [1]
     the  professional  association  of  physicians  administering HBO
     therapy, and  we  briefly  review  the  data  supporting  current
     indications.
 
     MECHANISMS OF ACTION
 
     Pressure
     In  disease  such as air embolism and decompression sickness, the
     therapeutic  effect  of  HBO  therapy  is  achieved  through  the
     mechanical reduction in bubble size  brought on by an increase in
     ambient pressure. A 5 atm a bubble  is  reduced  to  20%  of  its
     original volume and 60% of its original diameter.
 
     Increasing   pressure  in  HBO  therapy  is  often  expressed  in
     multiples of atmospheric pressure absolute  (ATA); 1 ATA equals 1
     kg/c[m.sup.2] or 735.5 mm Hg. Most HBO treatments  are  performed
     at  2 to 3 ATA. In air embolism and decompression sickness, where
     pressure is crucial to  therapeutic effect, treatments frequently
     start at 6 ATA.
 
     This additional pressure, when  associated  with  inspiration  of
     high  levels  of  oxygen,  substantially  increases  the level of
     oxygen dissolved into blood plasma. This state of serum hyperoxia
     is the second beneficial effect of hyperbaric oxygen therapy.
 
     Hyperoxia: Life Without Blood
     At  sea  level  in  room  air,  hemoglobin  is  approximately 97%
     saturated with oxygen (19.5 vol% oxygen, of  which  approximately
     5.8  vol% is extracted by tissue). The amount of oxygen dissolved
     into plasma  is  0.32  vol%.  An  increase  in  P[O.sub.2]  has a
     negligible impact on total hemoglobin oxygen content; however, it
     does result in an increase  in  the  amount  of  oxygen  dissolve
     directly  into  plasma.  With  100% inspired oxygen the amount of
     plasma oxygen increases to  2.09  vol%.  At 3 ATA plasma contains
     6.8 vol%  oxygen,  a  level  equivalent  to  the  average  tissue
     requirements  for  oxygen.  Thus,  HBO  treatment  could  and has
     sustained life without hemoglobin. [4]
 
     The immune  system,  wound  healing,  and  vascular  tone are all
     affected  by  oxygen  supply.  Oxygen  alone  has  little  direct
     antimicrobial  effect,  even  for  most  anaerobes  [5];  it  is,
     however, a crucial factor in immune function.
 
     Neutrophils require molecular oxygen as a substrate for microbial
     killing.  The  oxidative  burst   seen   in   neutrophils   after
     phagocytosis  of  bacteria  involves  a 10-to 15-fold increase in
     oxygen consumption. [6] Here oxygen  serves as a substrate in the
     formation of free radicals, which directly or indirectly initiate
     phagocytic killing. [7] This endogenous  antimicrobial  system
     virtually  ceases  functioning under conditions of hypoxia. A
     tissue [PO.sub.2] of at least  30  mm  Hg of oxygen is considered
     necessary for normal oxidative  function  to  occur.  [8]  Oxygen
     partial  pressures  below  this  are  often  seen  in damaged and
     infected tissues. Increasing the oxygen  level in this tissue can
     allow restoration of white blood  cell  function  and  return  of
     adequate  antimicrobial action. [9] The cardiovascular effects of
     hyperbaric oxygen include  a  generalized  vasoconstriction and a
     small reduction in  cardiac  output.  [10]  This  ultimately  may
     decrease  the  overall blood supply to a region, but the increase
     in serum oxygen content results  in  an overall gain in delivered
     oxygen. In conditions such as burns, cerebral  edema,  and  crush
     injuries, this vasoconstriction may be beneficial, reducing edema
     and tissue swelling while main taining tissue oxygenation. [11]
 
     COMPLICATIONS
 
     Usual  complications  of  HBO therapy are listed in Table 2. They
     are a result  of  either  barometric  pressure  changes or oxygen
     toxicity. The most common complications involve cavity trauma due
     to change in pressure. [12] Any  air-filled  cavity  that  cannot
     equilibrate  with  ambient  pressure, such as the middle ear when
     the eustachian  tube  is  blocked,  is  subject  to deformity and
     barotrauma during pressure changes in HBO therapy.
 
     Pneumothorax is a  rare  complication  of  HBO  treatment,
     usually occurring only in patients with severe lung disease.
 
     Air  embolism,  presumably  resulting from a small tear in
     the pulmonary vasculature, is another rare complication. [13] One
     hundred percent oxygen under high  pressure is neurotoxic and can
     lower the seizure threshold and  affect  central  nervous  system
     control  of  respiration. However, neurotoxicity is rare with the
     low-pressure, short-duration  treatments  used  clinically in HBO
     therapy. In one series the incidence was reported as 1.3 seizures
     per 10 000 treatments. [14]
 
     Pulmonary oxygen toxic reactions can  occur  with  100%  inspired
     oxygen  at  less  than  1 ATA with prolonged exposure. Almost all
     patients will show pulmonary toxicity after 6 continuous hours of
     inspired oxygen at 2 ATA.  [15] No clinical HBO protocol requires
     this length of continuous exposure to 100% oxygen.  However,  HBO
     treatments  may  contribute to the pulmonary oxygen toxicity seen
     in critically ill  patients  who  receive  high concentrations of
     inspired oxygen between hyperbaric treatments.
 
     Although a concern in premature newborns, retrolental fibroplasia
     has not been noted in infants, children, or adults undergoing HBO
     therapy. [16] Development  of  cataracts  has  been  reported  in
     patients receiving more than 150 HBO treatments. [17]
 
     HBO ADMINISTRATION
 
     Hyperbaric oxygen can be administered in either a multiplace or a
     monoplace chamber.
 
     Multiplace Chamber
 
     Multiplace  chambers are large tanks accommodating 2 to 14 people
     (Fig 1). They are usually built  to achieve pressures up to 6 atm
     and have a chamber lock-entry system  that  allows  personnel  to
     pass  through without altering the pressure of the inner chamber.
     Patients can be directly  cared  for  by medical staff within the
     chamber. The chamber is  filled  with  compressed  air;  patients
     breathe   100%   oxygen  through  a  face  mask,  head  hood,  or
     endotracheal tube.  Although  fire  hazards  restrict  the use of
     certain electronic equipment, some monitors and ventilators  with
     solid-state  circuitry  can  be used within the chamber, allowing
     intensive care of  critically  ill  patients. [18] The multiplace
     chamber's ability to maintain pressures of 6 atm or  more,  makes
     it  the  chamber  of  choice  for  decompression sickness and air
     embolism.
 
     Monoplace Chamber
 
     Monoplace chambers (Fig 2) are  far less costly than their larger
     counterparts and have allowed hospitals to institute HBO programs
     without prohibitive capital outlays. Most chambers are  sized  to
     allow  a single patient to lie supine under a transparent acrylic
     dome or viewing  port.  The  internal  environment of a monoplace
     chamber is maintained at 100% oxygen; thus, the patient does  not
     wear  a mask. This high concentration of oxygen precludes the use
     of any electronic  equipment  in  the chamber. However, specially
     adapted ventilators and monitoring systems do allow treatment  of
     critically ill patients.
 
     CLINICAL INDICATIONS
 
     Acute Conditions
 
     Decompression Sickness:
     Although occasionally seen in aviators, decompression sickness is
     generally  a  disease  of  divers.  During  a  dive, the diver is
     exposed to pressures greater  than  1  atm,  and tissue uptake of
     nitrogen increases according to the principles  of  Henry's  law.
     With  ascent,  a  pressure gradient develops, and nitrogen leaves
     the tissue, dissolving into the  blood  and passing to the lungs,
     where it is exhaled. With rapid ascent a steep pressure  gradient
     develops  and intravascular nitrogen gas bubbles form. [19] These
     can  be  detected  in  asymptomatic  divers.  [20]  With  greater
     pressure gradients, the nitrogen  bubbles become large enough and
     prevalent enough to mechanically deform tissue and obstruct blood
     vessels. The gas-fluid interface also interacts with blood cells,
     platelets, and proteins, causing disruption of the  intravascular
     coagulation system. [21] Decompression sickness results.
 
     Divers  can  experience  decompression  sickness  as  pain  only,
     usually  as  a  "deep  and  dull  ache"  in the extremities. More
     serious  cases  can  present   as  paraplegia  or  cardiovascular
     collapse due to embolization  of  bubbles  into  the  cardiac  or
     central nervous system.
 
     Hyperbaric  oxygen therapy mechanically decreases the size of the
     bubbles, oxygenates  ischemic  tissue,  and  reduces the nitrogen
     gradient. Any  patient  with  decompression  sickness  should  be
     transferred  immediately  to  the  nearest  HBO facility with the
     capacity to decompress to 3 to  6  ATA, as this has been shown in
     numerous series to be the most reliable and effective  treatment.
     [22,23]  The  Duke  University  Divers  Alert Network maintains a
     24-hour emergency consultation  telephone number, (919) 684-8111,
     and can identify the closest available HBO facility.
 
     Air Embolism.
 
     Air embolism can be a  complication  of  uncontrolled  ascent  in
     diving  but  more  frequently  is  seen  medically  in iatrogenic
     misadventures. Bubbles can  embolize  to  the cerebral or cardiac
     circulation,  producing  either  severe  neurologic  symptoms  or
     sudden  death.  Hyperbaric  oxygen  therapy  has  been  part   of
     successful  treatment  of  air  embolism  due  to  cardiovascular
     procedures,  [24,25]  lung  biopsies, [26] hemodialysis, [27] and
     central line placement.  [28]  Presumably,  HBO therapy decreases
     the volume of the embolism and oxygenates local tissues.
 
      Treatment involves immediate descent to  6  ATA  for  15  to  30
     minutes  on  air, followed by decompression to 2.8 ATA, where the
     patient  receives  prolonged  oxygen  treatment.  Carbon Monoxide
     Poisoning.—Carbon monoxide poisoning accounts  for  half  of  all
     fatal poisonings in the United States. Multiple series have shown
     that  patients  with  carbon  monoxide poisoning improve markedly
     following treatment with HBO. [29-31] However, both the mechanism
     of carbon monoxide toxicity and the therapeutic effect of HBO are
     poorly understood. Carbon monoxide  toxicity  was long thought to
     be due to anoxia alone; [32] however, there is evidence that  the
     pathophysiologic  effects  occur  with carbon monoxide binding to
     the   cytochrome-oxidase   system,    causing   anoxia   at   the
     mitochondrial level. [33] In either case, HBO therapy is the most
     rapid way of displacing carbon monoxide bound to  hemoglobin  and
     cytochromes.   The   serum   half-life  of  carboxyhemoglobin  is
     decreased from 5 hours  20  minutes  with  room air to 80 minutes
     with 100% oxygen and 23 minutes with 100% oxygen at 3  ATA.  [34]
     In  treating  patients  with  carbon  monoxide  poisoning,  it is
     important to remember that serum carboxyhemoglobin levels do no t
     reflect tissue levels  of  carboxyhemoglobin  and, therefore, may
     not correlate with the degree of toxicity. Accompanying signs and
     symptoms are  as  important  to  guiding  therapy  as  the  serum
     carboxyhemoglobin  level.  [35]  Although HBO therapy remains the
     preferred treatment for  significant  exposure  (Table 3), only a
     few controlled  human  studies  with  inconclusive  results  have
     compared HBO with 100% oxygen at 1 atm. [36,37]
 
     Clostridial Myonecrosis.
 
     Clostridial  myonecrosis occurs when a hypoxic environment within
     a  necrotic  wound  allows   clostridial  spores  to  convert  to
     vegetative organisms.  These  organisms  produce  exotoxins  that
     destroy red blood cells, cause tissue necrosis, and abolish local
     host  defenses.  The  most  important  exotoxin is alpha toxin. A
     tissue [PO.sub.2] of 250 mm  Hg  inhibits the production of alpha
     toxin by Clostridium. [38]
 
     Hyperbaric oxygen is commonly  used  as  an  adjunct  therapy  in
     clostridial   infections.   In  vivo  studies  have  demonstrated
     decreased mortality rates and  diminished tissue loss in infected
     mice. [39,40] In a study by DeMello et al, [41] using a dog model
     of clinical Clostridium infection, 100% of infected control  dogs
     and  dogs randomized to either HBO therapy or surgery died. Fifty
     percent of the dogs  that  received  antibiotics survived, 70% of
     the  dogs  that  received  antibiotics  and   underwent   surgery
     survived,  and  95% of the dogs that received antibiotics and HBO
     therapy and underwent surgery survived.
 
     Multiple series  have  evaluated  the  effect  of  HBO therapy on
     clostridial infections in humans.  [42,43]  Surgeons  experienced
     with  its use emphasize that early HBO treatment reduces systemic
     toxic reactions so that  patients  in  shock seem more stable and
     better able to tolerate surgery, and there is clearer demarcation
     of viable and nonviable tissue.  There  have,  however,  been  no
     randomized, controlled studies.
 
     Hyperbaric  oxygen  therapy has been recommended for treatment of
     necrotizing fasciitis, since  anaerobic  bacteria  play a role in
     the  disease.  [44,45]  The  diversity  of  clinical  states   in
     retrospective  studies  and the paucity of experimental data make
     it  difficult  to  demonstrate  the  effect  of  HBO  therapy  on
     nonclostridial   soft-tissue   infection.   Although  necrotizing
     fasciitis is an accepted indication  for  HBO,  the  benefit  HBO
     therapy  may  provide  is  still  poorly  understood, and surgery
     remains the cornerstone of therapy. [46]
 
     Acute Traumatic  Ischemia.
     Acute crush injury to  an  extremity  may  cause severe edema and
     ischemia in tissue and capillary beds not relieved by restoration
     of arterial perfusion. Hyperbaric oxygen therapy may aid  salvage
     during  the  acute  stages of revascularization by reducing edema
     via vasoconstriction and  increasing  oxygen  delivery via plasma
     flow. [47] Investigators have used HBO therapy successfully as an
     adjunct to surgery in crush injuries. [48,49] Additional evidence
     has demonstrate d that HBO therapy may also serve as  an  adjunct
     therapy in the compartment syndrome. [50]
 
     CHRONIC CONDITIONS
 
     Irradiated Tissue.
     Radiation  therapy,  in  addition to its therapeutic effects, can
     damage normal adjacent tissue.  The initial pathologic process is
     a progressive obliterative endarteritis, resulting  in  areas  of
     tissue  hypoxia  and  eventual  cell  death.  [51] Large areas of
     hypocellular, hypovascular, and  hypoxic  tissue are created that
     are devoid of functioning fibroblasts and osteoblasts. [52]
 
     Hyperbaric oxygen therapy appears to  assist  in  salvaging  such
     tissue   by  stimulating  angioneogenesis  in  marginally  viable
     tissue.  [53]  Marx   and   Johnson   [54]   emphasize  that,  in
     reconstructive  surgery  involving  recently  irradiated  tissue,
     presurgical HBO treatment can help  promote  a  well-vascularized
     wound  bed that will enhance reconstruction and graft take. Using
     a  specific  HBO   protocol   of   presurgical  and  postsurgical
     treatments, they demonstrated a satisfactory surgical outcome  in
     92% of their patients and a complication rate of 9%.
 
     In osteoradionecrosis, tissue destruction progresses to breakdown
     of  overlying  tissues and symptomatic destruction of bone. Prior
     to the introduction of HBO  therapy,  only  5% to 30% of patients
     who developed  osteoradionecrosis  could  expect  remission  with
     conservative  therapy. [55] In a protocol developed by Marx, [56]
     a series  of  58  patients  received  an  initial  series  of HBO
     treatments, followed by debridement and further HBO treatment, as
     dictated by their clinical course. All 58  patients  studied  had
     resolution  of  symptoms of osteoradionecrosis, with good results
     on  long-term  follow  up.  These  impressive  results  have been
     corroborated by others. [57,58] Successful results have also been
     demonstrated  for  radiation-induced  cystitis  [59]  and   other
     radiation-damaged  soft tissue. [60] Hyperbaric oxygen therapy is
     beneficial  for  patients   at   risk   for  the  development  of
     osteoradionecrosis, such as irradiated patients  requiring  tooth
     extraction.  In  a  randomized trial comparing HBO and penicillin
     therapy  in  74  pr  eviously  irradiated  patients,  30%  of the
     patients who received  penicillin  developed  osteoradionecrosis,
     while   5.4%   of   the   patients  who  received  HBO  developed
     osteoradionecrosis.  [61]  Similar  results  have  been  reported
     elsewhere. [62]
 
     Refractory Osteomyelitis.
     Hyperbaric  oxygen  is  currently  being  used  as  an adjunctive
     therapy with debridement and antibiotics  in  osteomyelitis  that